Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
I had to test it myself
Discontinuation criteria protect patients from progressive organ damage: AST/ALT exceeding 40 IU/L Bilirubin above 21 mol/L Creatinine surpassing 90 mol/L in females These safety parameters require immediate cessation of therapy to prevent irreversible organ damage
These studies highlight the critical role of MIF in promoting tumor-associated MDSC phenotypes
The pathway is finely tuned by both nitric oxide synthase (NOS) and asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NOS
US$ 25.50
US$ 22.80
US$ 25.29
